NovaBridge Biosciences (NBP) Operating margin 2022–2025
NovaBridge Biosciences (NBP) operating margin by fiscal year — reported operating income divided by reported revenue.
-14916.0%FY2025 · since FY2022: -22.5% → -14916.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -14916.0% | — |
| FY2023 | -521.4% | -498.9 pp |
| FY2022 | -22.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice